エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/10/23 | 6,534 | 6,534 | 6,534 | 6,534 | +1,000 | +18.1% | 245,900 |
| 2019/10/21 | 5,601 | 5,607 | 5,528 | 5,534 | -16 | -0.3% | 514,700 |
| 2019/10/18 | 5,555 | 5,612 | 5,541 | 5,550 | +8 | +0.1% | 744,600 |
| 2019/10/17 | 5,588 | 5,626 | 5,532 | 5,542 | -23 | -0.4% | 733,700 |
| 2019/10/16 | 5,565 | 5,612 | 5,550 | 5,565 | +77 | +1.4% | 862,000 |
| 2019/10/15 | 5,525 | 5,559 | 5,469 | 5,488 | +52 | +1% | 821,500 |
| 2019/10/11 | 5,375 | 5,446 | 5,331 | 5,436 | +140 | +2.6% | 1,065,700 |
| 2019/10/10 | 5,335 | 5,340 | 5,230 | 5,296 | -33 | -0.6% | 750,200 |
| 2019/10/09 | 5,380 | 5,409 | 5,297 | 5,329 | -122 | -2.2% | 955,000 |
| 2019/10/08 | 5,420 | 5,489 | 5,414 | 5,451 | +46 | +0.9% | 735,200 |
| 2019/10/07 | 5,425 | 5,440 | 5,371 | 5,405 | -7 | -0.1% | 429,400 |
| 2019/10/04 | 5,344 | 5,416 | 5,330 | 5,412 | +78 | +1.5% | 768,200 |
| 2019/10/03 | 5,350 | 5,403 | 5,306 | 5,334 | -113 | -2.1% | 965,000 |
| 2019/10/02 | 5,494 | 5,494 | 5,424 | 5,447 | -85 | -1.5% | 1,000,900 |
| 2019/10/01 | 5,514 | 5,543 | 5,467 | 5,532 | +41 | +0.7% | 719,800 |
| 2019/09/30 | 5,490 | 5,507 | 5,422 | 5,491 | -2 | ±0% | 1,090,000 |
| 2019/09/27 | 5,600 | 5,618 | 5,436 | 5,493 | -144 | -2.6% | 1,242,400 |
| 2019/09/26 | 5,759 | 5,760 | 5,603 | 5,637 | -22 | -0.4% | 1,518,300 |
| 2019/09/25 | 5,420 | 5,696 | 5,420 | 5,659 | +257 | +4.8% | 1,837,400 |
| 2019/09/24 | 5,494 | 5,537 | 5,402 | 5,402 | -24 | -0.4% | 1,385,500 |
| 2019/09/20 | 5,430 | 5,514 | 5,398 | 5,426 | +14 | +0.3% | 1,397,500 |
| 2019/09/19 | 5,339 | 5,456 | 5,335 | 5,412 | +100 | +1.9% | 1,318,700 |
| 2019/09/18 | 5,347 | 5,419 | 5,284 | 5,312 | -76 | -1.4% | 1,410,000 |
| 2019/09/17 | 5,330 | 5,416 | 5,258 | 5,388 | -132 | -2.4% | 2,236,700 |
| 2019/09/13 | 5,516 | 5,536 | 5,450 | 5,520 | +54 | +1% | 1,800,300 |
| 2019/09/12 | 5,541 | 5,547 | 5,451 | 5,466 | -41 | -0.7% | 1,027,000 |
| 2019/09/11 | 5,499 | 5,519 | 5,446 | 5,507 | +129 | +2.4% | 1,005,000 |
| 2019/09/10 | 5,379 | 5,393 | 5,344 | 5,378 | +28 | +0.5% | 635,300 |
| 2019/09/09 | 5,313 | 5,355 | 5,304 | 5,350 | +62 | +1.2% | 636,300 |
| 2019/09/06 | 5,309 | 5,334 | 5,260 | 5,288 | +3 | +0.1% | 913,200 |
| 2019/09/05 | 5,240 | 5,379 | 5,221 | 5,285 | +70 | +1.3% | 1,189,800 |
| 2019/09/04 | 5,264 | 5,291 | 5,205 | 5,215 | -73 | -1.4% | 929,900 |
| 2019/09/03 | 5,321 | 5,353 | 5,279 | 5,288 | -49 | -0.9% | 621,400 |
| 2019/09/02 | 5,330 | 5,345 | 5,282 | 5,337 | -93 | -1.7% | 761,400 |
| 2019/08/30 | 5,360 | 5,456 | 5,341 | 5,430 | +127 | +2.4% | 1,002,800 |
| 2019/08/29 | 5,321 | 5,345 | 5,273 | 5,303 | -2 | ±0% | 568,300 |
| 2019/08/28 | 5,322 | 5,348 | 5,278 | 5,305 | -17 | -0.3% | 761,000 |
| 2019/08/27 | 5,361 | 5,398 | 5,319 | 5,322 | +29 | +0.5% | 787,900 |
| 2019/08/26 | 5,245 | 5,324 | 5,245 | 5,293 | -102 | -1.9% | 799,600 |
| 2019/08/23 | 5,350 | 5,448 | 5,350 | 5,395 | -34 | -0.6% | 468,900 |
| 2019/08/22 | 5,483 | 5,488 | 5,388 | 5,429 | -61 | -1.1% | 567,700 |
| 2019/08/21 | 5,412 | 5,502 | 5,397 | 5,490 | -7 | -0.1% | 479,300 |
| 2019/08/20 | 5,408 | 5,505 | 5,383 | 5,497 | +111 | +2.1% | 607,700 |
| 2019/08/19 | 5,400 | 5,427 | 5,347 | 5,386 | +26 | +0.5% | 408,500 |
| 2019/08/16 | 5,299 | 5,371 | 5,291 | 5,360 | +35 | +0.7% | 542,200 |
| 2019/08/15 | 5,298 | 5,350 | 5,265 | 5,325 | -113 | -2.1% | 736,300 |
| 2019/08/14 | 5,459 | 5,482 | 5,394 | 5,438 | +44 | +0.8% | 541,200 |
| 2019/08/13 | 5,411 | 5,457 | 5,372 | 5,394 | -110 | -2% | 720,600 |
| 2019/08/09 | 5,536 | 5,581 | 5,473 | 5,504 | -31 | -0.6% | 710,300 |
| 2019/08/08 | 5,511 | 5,545 | 5,455 | 5,535 | +10 | +0.2% | 476,000 |
1351～
1400
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
